Summary of breast cancer program activities
Almost 80% of women diagnosed with breast cancer in the GAHDA breast cancer program have the kind of cancer that is treated with an oral chemotherapy medication called tamoxifen. To support this long-term treatment, a laminated card explaining common side effects, and written in Kreyol has been discussed and distributed to patients/families and providers. A donor is contributing funds so all women have enough medicine for daily doses. The photo below shows nurse navigator, Leila Casseus giving one -month supply. As of December, 14 women were taking this medication and being monitored for secondary effects.
Autor: GAHDA
Date: 23 June 2024
